DIETRA ANGELLY: Open Payments
NPI 1902371313 · MARION, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$455 in 26 payments from 8 companies in 2025. Trend: 2023 $153 · 2024 $1,286 · 2025 $455
Food & beverage: $455
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $223 |
| Lilly USA, LLC | 3 | $58 |
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
| Novo Nordisk Inc | 2 | $40 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $31 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: VRAYLAR, QULIPTA, MOUNJARO, UBRELVY, REXULTI, CAPLYTA, Ozempic, GEMTESA.
Industry payments across IL — which companies pay providers there.
